Table 2.
Characteristics of patients with an IBD diagnosis undergoing emergency total colectomy in the period 1996–2010 in Denmark
| Ulcerative colitis | Crohn's disease | Ulcerative colitis and Crohn's disease* | |
| Total number (n=1439) | 1056 (73.4%) | 136 (9.5%) | 247 (17.2%) |
| Males | 559 (52.9%) | 62 (45.6%) | 113 (45.7%) |
| Females | 497 (47.1%) | 74 (54.4%) | 134 (54.3%) |
| Age at operation | |||
| 0–39 years | 503 (47.6%) | 56 (41.2%) | 134 (54.3%) |
| 40–59 years | 286 (27.1%) | 39 (28.7%) | 65 (26.3%) |
| ≥60 years | 267 (25.3%) | 41 (30.1%) | 48 (19.4%) |
| Number of annual colectomies for IBD performed in the surgical department | |||
| ≤3/year | 168 (15.9%) | 31 (22.8%) | 43 (17.4%) |
| 3–12/year | 186 (17.6%) | 24 (17.6%) | 50 (20.2%) |
| >12/year | 702 (66.5%) | 81 (59.6%) | 154 (62.4%) |
| Duration of hospitalisation before colectomy | |||
| Admitted <8 days before colectomy | 296 (28.0%) | 45 (33.1%) | 85 (34.4%) |
| Admitted ≥8 days before colectomy | 760 (72.0%) | 91 (66.9%) | 162 (65.6%) |
| Medical treatment within 1 year before colectomy | |||
| TNF-α and cyclosporine | 67 (6.3%) | 12 (8.8%) | 23 (9.3%) |
| Reoperation within 30 days postoperatively | 102 (9.7%) | 11 (8.2%) | 27 (10.9%) |
| Charlson Comorbidity Index Score | |||
| 0 | 810 (76.7%) | 96 (70.6%) | 191 (77.3%) |
| 1–2 | 194 (18.4%) | 30 (22.1%) | 49 (19.8%) |
| ≥3 | 52 (4.9%) | 10 (7.3%) | 7 (2.8%) |
| Colectomy type | |||
| Colectomy with ileorectal anastomosis (KJFH00—01) | 38 (3.6%) | 16 (11.8%) | 19 (7.7%) |
| Colectomy with ileostomy (KJFH10—11) | 875 (82.9%) | 97 (71.3%) | 196 (74.4%) |
| Proctocolectomy with ileostomy (KJFH20—21) | 73 (6.9%) | 8 (5.9%) | 21 (8.5%) |
| Restorative proctocolectomy ± ileostomy (KJFH30—33) | 31 (2.9%) | 2 (1.5%) | 4 (1.6%) |
| Proctocolectomy with Koch reservoir (KJFH40) | 1 (0.1%) | 0 (0%) | 0 (0%) |
| Other form of colectomy (KJFH96) | 38 (3.6%) | 13 (9.6%) | 7 (2.8%) |
| Time period | |||
| 1996–2000 | 371 (35.1%) | 54 (39.7%) | 90 (36.4%) |
| 2001–2005 | 385 (36.5%) | 36 (7.1%) | 84 (34.0%) |
| 2006–2010 | 300 (28.4%) | 46 (11.0%) | 73 (30.0%) |
*
Patients for whom codes for both ulcerative colitis and Crohn's disease were used at any preceding or subsequent admission or hospital contact.
IBD, inflammatory bowel disease; TNF, tumour necrosis factor.